Gimeracil sensitizes cells to radiation via inhibition of homologous recombination
- 31 August 2010
- journal article
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 96 (2), 259-266
- https://doi.org/10.1016/j.radonc.2010.05.020
Abstract
No abstract availableFunding Information
- Bundesministerium für Bildung und Forschung
- Sapporo Medical University
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 25 references indexed in Scilit:
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trialThe Lancet Oncology, 2008
- Multi-institutional phase II trial of S-1 in patients with oral squamous cell carcinomaAnti-Cancer Drugs, 2008
- Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral FluoropyrimidineThe New England Journal of Medicine, 2007
- Phase-I trial of oral fluoropyrimidine anticancer agent (S-1) with concurrent radiotherapy in patients with unresectable pancreatic cancerBritish Journal of Cancer, 2007
- EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancerBritish Journal of Cancer, 2003
- Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancerBritish Journal of Cancer, 2001
- The Forkhead-associated Domain of NBS1 Is Essential for Nuclear Foci Formation after Irradiation but Not Essential for hRAD50·hMRE11·NBS1 Complex DNA Repair ActivityOnline Journal of Public Health Informatics, 2001
- Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulatorsAnti-Cancer Drugs, 1996
- Ku86 Defines the Genetic Defect and Restores X-Ray Resistance and V(D)J Recombination to Complementation Group 5 Hamster Cell MutantsMolecular and Cellular Biology, 1996
- Restoration of X-ray Resistance and V(D)J Recombination in Mutant Cells by Ku cDNAScience, 1994